Show simple item record

dc.contributor.authorBrown, AR
dc.contributor.authorGreen, J
dc.contributor.authorMoreman, J
dc.contributor.authorGunnarsson, L
dc.contributor.authorMourabit, S
dc.contributor.authorBall, J
dc.contributor.authorWinter, M
dc.contributor.authorTrznadel, M
dc.contributor.authorCorreia, A
dc.contributor.authorHacker, C
dc.contributor.authorPerry, A
dc.contributor.authorWood, M
dc.contributor.authorHetheridge, M
dc.contributor.authorCurrie, R
dc.contributor.authorTyler, C
dc.date.accessioned2018-12-17T13:15:04Z
dc.date.issued2018-12-06
dc.description.abstractThe plastic monomer bisphenol A (BPA) is one of the highest production volume chemicals in the world and is frequently detected in wildlife and humans, particularly children. BPA has been associated with numerous adverse health outcomes relating to its estrogenic and other hormonal properties, but direct causal links are unclear in humans and animal models. Here we simulated measured (1×) and predicted worst-case (10×) maximum foetal exposures for BPA, or equivalent concentrations of its metabolite MBP, using fluorescent reporter embryo-larval zebrafish capable of quantifying Estrogen Response Element (ERE) activation throughout the body. Heart valves were primary sites for ERE activation by BPA and MBP, and transcriptomic analysis of micro-dissected heart tissues showed that both chemicals perturbed similar downstream molecular pathways and biological processes, including down-regulation of cartilage morphogenesis and filamentous protein synthesis. Collagen/keratin deficiency and impact on heart valve structural integrity were confirmed by histopathology for high-level MBP exposure, and structural defects (abnormal curvature) of the atrio-ventricular valves corresponded with impaired cardiovascular function (reduced ventricular beat rate and blood flow). Our results are the first to demonstrate plausible mechanistic links between ERE activation in the heart valves by BPA’s reactive metabolite MBP and the development of valvular- cardiovascular disease states.en_GB
dc.description.sponsorshipBiotechnology & Biological Sciences Research Council (BBSRC)en_GB
dc.description.sponsorshipNatural Environment Research Council (NERC)en_GB
dc.identifier.citationVol. 53 (1), pp. 463-474en_GB
dc.identifier.doi10.1021/acs.est.8b04281
dc.identifier.grantnumberBB/L01548X/1en_GB
dc.identifier.grantnumberNE/L007371/1en_GB
dc.identifier.grantnumber620033640en_GB
dc.identifier.grantnumber610040829en_GB
dc.identifier.urihttp://hdl.handle.net/10871/35181
dc.language.isoenen_GB
dc.publisherAmerican Chemical Societyen_GB
dc.rightsThis is an open access article published under a Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.en_GB
dc.subjectBPAen_GB
dc.subjectmetaboliteen_GB
dc.subjectMBPen_GB
dc.subjectendocrineen_GB
dc.subjecteffectsen_GB
dc.subjectestrogenicen_GB
dc.subjectheart valvesen_GB
dc.subjecttransgenicen_GB
dc.subjectzebrafishen_GB
dc.titleCardiovascular Effects and Molecular Mechanisms of Bisphenol A and Its Metabolite MBP in Zebrafishen_GB
dc.typeArticleen_GB
dc.date.available2018-12-17T13:15:04Z
dc.identifier.issn0013-936X
dc.description This is the author accepted manuscript. The final version is available on open access from American Chemical Society via the DOI in this record en_GB
dc.identifier.journalEnvironmental Science and Technologyen_GB
dc.rights.urihttps://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.htmlen_GB
dcterms.dateAccepted2018-12-06
exeter.funder::Biotechnology & Biological Sciences Research Council (BBSRC)en_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2018-12-06
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2018-12-16T13:53:56Z
refterms.versionFCDAM
refterms.dateFOA2019-02-18T12:42:28Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record